Tres Cantos, Spain

Ma Jesus Almel Armendariz


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ma Jesus Almel Armendariz: Innovator in Antiviral Polymer Development

Introduction

Ma Jesus Almel Armendariz is a prominent inventor based in Tres Cantos, Spain. With a focus on innovative solutions in the field of pharmaceuticals, she has made significant contributions to antiviral therapies through her groundbreaking research.

Latest Patents

Armendariz holds a notable patent for a "Process for Obtaining Polymers with Antiviral Activity." This process involves the reaction of molecules with carbonyl and hydroxyl groups, as well as amino and sulfonated groups, which occur in water or mixtures of water with water-miscible solvents. The specific reaction conditions, including temperature, time, and pH, are critical to the success of the process. The resultant polymeric material boasts a molecular weight ranging between 1,500 and 100,000, demonstrating antiviral activity with low toxicity and anticoagulant properties, making it suitable for both topical and systemic applications in humans and animals.

Career Highlights

Currently, Ma Jesus Almel Armendariz is affiliated with Laboratorios Andromaco S.A., where she continues to advance her research in polymer chemistry and antiviral applications. Her dedication to innovation underscores her role within the company, driving forward the development of effective pharmaceutical solutions.

Collaborations

In her professional journey, Armendariz has collaborated with notable colleagues such as Juan Pablo Pivel Ranieri and Antonio F Guerrero Gomez-Pamo. These partnerships have enhanced her research efforts and facilitated advancements in the field of antiviral therapies.

Conclusion

Ma Jesus Almel Armendariz exemplifies the spirit of innovation through her work on antiviral polymers, showcasing the impact of scientific research on modern medicine. Her contributions not only reflect her expertise but also hold promise for future developments in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…